1. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2
- Author
-
Joshua VanHouten, Wonnam Kim, Peter A. Friedman, W. Bruce Sneddon, Pamela Dann, John J. Wysolmerski, Jaekwang Jeong, Catherine Sullivan, and Jungmin Choi
- Subjects
0301 basic medicine ,Scaffold protein ,Sodium-Hydrogen Exchangers ,Receptor, ErbB-2 ,media_common.quotation_subject ,Calcium pump ,Amino Acid Motifs ,PDZ domain ,Apoptosis ,Breast Neoplasms ,Biology ,Biochemistry ,Receptor tyrosine kinase ,Mice ,Plasma Membrane Calcium-Transporting ATPases ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Cell Line, Tumor ,medicine ,Animals ,Humans ,HSP90 Heat-Shock Proteins ,RNA, Messenger ,skin and connective tissue diseases ,Internalization ,neoplasms ,Molecular Biology ,Cell Proliferation ,media_common ,Gene Expression Profiling ,Cell Membrane ,Cell Biology ,Phosphoproteins ,medicine.disease ,Hsp90 ,Cell biology ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Microscopy, Fluorescence ,Gene Knockdown Techniques ,030220 oncology & carcinogenesis ,biology.protein ,Calcium ,Female ,sense organs ,Tyrosine kinase ,Signal Transduction - Abstract
We examined whether the scaffolding protein sodium-hydrogen exchanger regulatory factor 1 (NHERF1) interacts with the calcium pump PMCA2 and the tyrosine kinase receptor ErbB2/HER2 in normal mammary epithelial cells and breast cancer cells. NHERF1 interacts with the PDZ-binding motif in PMCA2 in both normal and malignant breast cells. NHERF1 expression is increased in HER2-positive breast cancers and correlates with HER2-positive status in human ductal carcinoma in situ (DCIS) lesions and invasive breast cancers as well as with increased mortality in patients. NHERF1 is part of a multiprotein complex that includes PMCA2, HSP90, and HER2 within specific actin-rich and lipid raft-rich membrane signaling domains. Knocking down NHERF1 reduces PMCA2 and HER2 expression, inhibits HER2 signaling, dissociates HER2 from HSP90, and causes the internalization, ubiquitination, and degradation of HER2. These results demonstrate that NHERF1 acts with PMCA2 to regulate HER2 signaling and membrane retention in breast cancers.
- Published
- 2017
- Full Text
- View/download PDF